Building a Global Patient Funnel to Predict Uptake for a Gene Therapy Across 15 Countries
Context: A global biotech developing an ex-vivo gene therapy for a rare neuromuscular disorder engaged Thelansis to build a cross-market patient funnel and uptake forecast. The therapy was approachin ...
How Thelansis helped a Pharma company mitigate LOE impact through Forecast Modelling & Market Analytics
Background: In 2024, a mid-size specialty pharma company approached Thelansis with a clear challenge: its hero product, a second-line therapy in a tightly contested market, was set to enter Loss of E ...
Building a Global Price Strategy: How Thelansis Helped a Biopharma Set the Right Launch Price Across 15 Markets
Background: A biopharma company was preparing to launch a first-in-class therapy in immunology TA. The asset showed strong clinical promise, but its commercial team faced a familiar challenge: every ...
Optimizing Biotech Investment Strategy in an Uncertain Market Landscape
Introduction: A US-based mid-size biotech firm was preparing for its upcoming investment cycle to broaden its therapeutic area focus. The team had strong scientific instincts but lacked a unified, ev ...
Strengthening Global Market Access Readiness Through Early Payer & HTA Planning
Introduction: A global biopharma company preparing to advance towards asset commercialisation approached Thelansis with a clear priority that they wanted to enter multiple markets with confidence tha ...
How Thelansis Supported a Mid-Sized Biopharma Company in Out-Licensing Their Novel IPF Asset
Introduction: During 2024, a mid-sized biopharma company from the European region was developing a novel systematic therapy for the treatment of IPF, seeking an evidence-backed structured partnership ...
Optimizing Multi-channel Distribution and Inventory Agility in Pharmaceutical Industry through Demand-Based Forecasting
Introduction: The pharma ecosystem is quite complex, wherein companies operate across various channels, ranging from hospital procurement networks to retail pharmacies. While this expands their marke ...
Smart Pipeline Decisions: AI-Powered Indication Prioritization for Oncology TA
Background: In the current scenario, the competitive landscape of oncology TA, where innovation moves rapidly, pharma companies face intense pressure to optimize their pipeline investments. With hund ...
Mapping the Future: Identifying High-value Therapy Area Strategy for Emerging Markets
Background: In an evolving global disease landscape, identifying the right therapy areas or indication setting for investment is a strategic move that defines a company's growth trajectory, especiall ...
The Analogue Advantage: A Smarter Way to derive the market uptake and New Product revenue Forecast
Background: Launching a new therapy in the oncology space is one of the most complex and challenging in the pharma and biotech industries. With evolving treatment landscapes, shifting market dynamics ...